Upside case
Bull case
$1887+42.1%
MTD would need investors to value it at roughly 41x earnings — about 12x more generous than today's 29x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Analysis OverviewHoldUpdated May 1, 2026
Mettler-Toledo International Inc. (MTD) Stock Analysis
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Analyst consensus
Hold
Covering
19
analysts
8 bullish · 0 bearish · 19 covering MTD
Strong Buy
0
Buy
8
Hold
11
Sell
0
Strong Sell
0
Consensus Target
$1491
+12.2% vs today
Scenario Range
$1010 – $1887
Model bear to bull value window
Coverage
19
Published analyst ratings
Valuation Context
28.6x
Forward P/E · Market cap $27.0B
MTD price targets
Three scenarios for where MTD stock could go
Current
~$1328
Confidence
64 / 100
Updated
May 1, 2026
Where we are now
Current · $1328
Bear
$1010
Base
$1559
Bull
$1887
Market caseClosest to today
Base case
$1559+17.4%
At 34x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
Stress case
Bear case
$1010-24.0%
If investor confidence fades or macro conditions deteriorate, a 7x multiple contraction could push MTD down roughly 24% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.
Mettler-Toledo International Inc.
MTD · NYSEHealthcareMedical - Diagnostics & ResearchDecember year-end
Mettler-Toledo is a global manufacturer of precision instruments and services for laboratory, industrial, and retail applications. It generates revenue primarily from selling laboratory instruments (~50% of sales), industrial weighing and inspection systems (~35%), and retail weighing solutions, with a growing service and software segment. The company's competitive moat lies in its precision engineering expertise, global service network, and the stickiness of its LabX software platform that integrates with its installed instrument base.
Market Cap
$27.0B
Revenue TTM
$4.0B
Net Income TTM
$869M
Net Margin
21.6%
MTD Revenue and Earnings Performance
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
EPS Beat Rate
92%Exceptional
12 quarters tracked
Revenue Beat Rate
75%Exceptional
vs consensus estimates
Avg EPS Surprise
+3.8%
above Street consensus
Beat / Miss Record
BeatMissLeft = EPS · Right = Revenue
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Last 4 Quarters
EPS beats: 4 of 4Q2 2025
EPS
$8.19/$7.88
Revenue
$884M/$877M
Q3 2025
EPS
$10.09/$9.60
Revenue
$983M/$958M
Q4 2025
EPS
$11.15/$10.66
Revenue
$1.0B/$997M
Q1 2026
EPS
$13.36/$12.80
Revenue
$1.1B/$1.1B
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q2 2025 | $8.19/$7.88 | +3.9% | $884M/$877M | +0.8% |
| Q3 2025 | $10.09/$9.60 | +5.1% | $983M/$958M | +2.7% |
| Q4 2025 | $11.15/$10.66 | +4.6% | $1.0B/$997M | +3.3% |
| Q1 2026 | $13.36/$12.80 | +4.4% | $1.1B/$1.1B | +2.3% |
FY1–FY2 Estimates
Revenue Outlook
FY1
$4.2B
+3.8% YoY
FY2
$4.3B
+3.6% YoY
EPS Outlook
FY1
$46.01
+7.9% YoY
FY2
$49.52
+7.6% YoY
Trailing FCF (TTM)$849M
FCF Margin: 21.1%
Next Earnings
May 7, 2026
Expected EPS
$8.70
Expected Revenue
$943M
MTD beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
MTD Revenue Breakdown by Segment
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest disclosure
FY 2025
Total disclosed revenue $4.0B
Product Mix
Latest annual revenue by segment or product family
Laboratory products and services
55.7%
+2.5% YoY
Tap, hover, or focus a slice to inspect segment detail.
Geographic Mix
Latest annual revenue by reported region
Asia
100.0%
+1.7% YoY
Tap, hover, or focus a slice to inspect segment detail.
Laboratory products and services is the largest disclosed segment at 55.7% of FY 2025 revenue, up 2.5% YoY.
Asia is the largest reported region at 100.0%, up 1.7% YoY.
MTD Valuation Snapshot
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Relative Value Signal
Fairly Valued
Fair value est. $1266 — implies -0.1% from today's price.
Premium to Fair Value
0.1%
above fair value
Deep DiscountFair ValueVery Expensive
vs S&P 500 Trailing P/E
MTD
31.5x
vs
S&P 500
25.2x
+25% premium
vs Healthcare Trailing P/E
MTD
31.5x
vs
Healthcare
22.1x
+42% premium
vs MTD 5Y Avg P/E
Today
31.5x
vs
5Y Average
37.3x
15% discount
Forward PE
28.6x
S&P 500
19.1x
+50%
Healthcare
19.0x
+50%
5Y Avg
—
—
Trailing PE
31.5x
S&P 500
25.2x
+25%
Healthcare
22.1x
+42%
5Y Avg
37.3x
-15%
PEG Ratio
2.84x
S&P 500
1.75x
+62%
Healthcare
1.52x
+86%
5Y Avg
—
—
EV/EBITDA
23.5x
S&P 500
15.3x
+54%
Healthcare
14.1x
+66%
5Y Avg
27.4x
-14%
Price/FCF
31.8x
S&P 500
21.3x
+49%
Healthcare
18.7x
+71%
5Y Avg
37.8x
-16%
Price/Sales
6.7x
S&P 500
3.1x
+114%
Healthcare
2.8x
+135%
5Y Avg
8.0x
-16%
Dividend Yield
—
S&P 500
1.88%
—
Healthcare
1.40%
—
5Y Avg
—
—
| Metric | MTD | S&P 500 | Healthcare | 5Y Avg MTD |
|---|---|---|---|---|
| Forward PE | 28.6x | 19.1x+50% | 19.0x+50% | — |
| Trailing PE | 31.5x | 25.2x+25% | 22.1x+42% | 37.3x-15% |
| PEG Ratio | 2.84x | 1.75x+62% | 1.52x+86% | — |
| EV/EBITDA | 23.5x | 15.3x+54% | 14.1x+66% | 27.4x-14% |
| Price/FCF | 31.8x | 21.3x+49% | 18.7x+71% | 37.8x-16% |
| Price/Sales | 6.7x | 3.1x+114% | 2.8x+135% | 8.0x-16% |
| Dividend Yield | — | 1.88% | 1.40% | — |
MTD trades above S&P 500 benchmarks on 6 of 6 measured multiples — commands a broad premium across most valuation dimensions.
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolMTD Financial Health
Verdict
Exceptional
MTD generates $849M in free cash flow at a 21.1% margin — 40.0% ROIC signals a durable competitive advantage · returns 3.0% of market cap to shareholders annually.
Cash Engine
Revenue, margins, and cash generation
Revenue (TTM)
Trailing-twelve-month sales base
$4.0B
Revenue Growth
TTM vs prior year
+4.0%
Gross Margin
Gross profit as a share of revenue
57.5%
Operating Margin
Operating income divided by revenue
27.8%
Net Margin
Net income divided by revenue
21.6%
EPS (TTM)
Diluted earnings per share, trailing twelve months
$42.65
Free Cash Flow (TTM)
Cash generation after capex
$849M
FCF Margin
FCF as share of revenue — the primary cash quality signal
21.1%
Capital Quality
ROIC, leverage, and debt serviceability
ROIC
Return on invested capital — primary competitive quality signal
40.0%
ROA
Return on assets, trailing twelve months
25.1%
Cash & Equivalents
Liquid assets on the balance sheet
$67M
Net Debt
Total debt minus cash
$2.3B
Debt Serviceability
Net debt as a multiple of annual free cash flow
2.7× FCF
~2.7 years to full repayment at current FCF run-rate
ROE
Return on equity, trailing twelve months
—
Shareholder Returns
How capital is returned to owners
Total shareholder yield
3.0%
Dividend
—
Buyback
3.0%
Share Repurchases
Trailing buyback outflow — dollar magnitude of capital returned
$800M
Dividend / Share
Annualized trailing dividend per share
—
Payout Ratio
Share of earnings distributed as dividends
—
Shares Outstanding
Declining as buybacks retire shares
20M
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageMTD Stock Risk Factors
Key factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 29, 2026
High Risk
Valuation & Market Volatility
MTD stock trades at a high price-to-earnings (P/E) multiple, which can lead to significant price fluctuations if the company misses earnings expectations. Recent fluctuations indicate potential volatility for investors, posing a risk to stock performance.
High Risk
Global Exposure & Economic Factors
Mettler-Toledo has considerable exposure to global R&D spending, particularly in China and Europe. A mid-20s percentage drop in Food Retail and a forecasted 10% decrease in the Lab segment highlight potential revenue challenges amid broader economic headwinds.
Medium
Insider Selling
Recent insider selling, including shares sold by the CFO, raises concerns about internal confidence in the company's future prospects. Such actions may signal potential issues that could affect investor sentiment.
Medium
Acquisition Risks
Pursuing acquisitions carries inherent risks, including difficulties in integrating operations and potential departures of key employees. Additionally, new stock issuances related to acquisitions could dilute existing shareholders.
Medium
Geopolitical & Inflationary Pressures
Mettler-Toledo's business is susceptible to various risks, including inflation and geopolitical uncertainties such as the war in Ukraine and the Israel-Hamas conflict. These factors could adversely affect the company's operations and financial performance.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Why MTD Stock Could Outperform
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 29, 2026
Analyst Sentiment
A significant number of analysts have issued 'buy' ratings for MTD stock, with some even upgrading their ratings from 'hold' to 'buy.' This indicates growing confidence in the company's future prospects among market experts.
Revenue and Earnings Growth
Mettler-Toledo has demonstrated consistent revenue growth, with recent quarterly earnings surpassing expectations. For instance, in Q4 2025, reported sales increased by 8% year-over-year, and adjusted EPS saw an 8% increase.
Market Position and Growth Potential
The company holds a strong market position, particularly in weighing instrumentation, where it leads the market and controls over 50% of the lab balances market. Analysts anticipate continued growth, with expected adjusted EPS increases of 6-8% reflecting improved performance.
Operational Strength
Mettler-Toledo shows operational strength with slight expansions in adjusted operating margins and notable growth in service sales, indicating a robust service portfolio.
Sector Tailwinds
The outlook for the pharmaceutical sector in the Americas and impressive growth in the food retail segment signal positive momentum, suggesting potential upside to market expectations.
Innovation and Strategic Focus
The company is investing in innovation, digitalization, and targeted acquisitions, which are expected to drive future growth.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
MTD Stock Price Performance
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Current Price
$1328.15
52W Range Position
58%
52-Week Range
Current price plotted between the 52-week low and high.
52-Week Low
$1052.05
+26.2% from the low
52-Week High
$1525.17
-12.9% from the high
1 Month
+4.86%
3 Month
-3.31%
YTD
-5.9%
1 Year
+24.9%
3Y CAGR
-1.6%
5Y CAGR
+0.5%
10Y CAGR
+14.0%
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
MTD vs Peers
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
Peer Set
Accurate peer set
Forward PE
28.6x
vs 19.7x median
+45% above peer median
Revenue Growth
+3.8%
vs +4.6% median
-18% below peer median
Net Margin
21.6%
vs 11.9% median
+81% above peer median
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
MTD MTD Mettler-Toledo International Inc. | $27.0B | 28.6x | +3.8% | 21.6% | Hold | +12.2% |
WAT WAT Waters Corporation | $22.8B | 24.3x | +33.4% | 11.9% | Hold | +15.2% |
A A Agilent Technologies, Inc. | $33.3B | 19.7x | +4.6% | 18.3% | Buy | +41.0% |
TMO TMO Thermo Fisher Scientific Inc. | $175.8B | 19.0x | +4.1% | 15.2% | Buy | +38.4% |
BRK BRKR Bruker Corporation | $6.4B | 20.0x | +10.4% | -0.8% | Buy | +23.2% |
FMC FMC FMC Corporation | $1.8B | 8.4x | -7.4% | -72.9% | Hold | +5.3% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
MTD Dividend and Capital Return
MTD returns 3.0% annually — null% through dividends and 3.0% through buybacks.
Dividend UnknownFCF Unknown
Total Shareholder Yield
3.0%
Dividend + buyback return per year
Buyback Yield
3.0%
Dividend Yield
—
Payout Ratio
—
Dividend Profile
Yield, cadence, and growth quality
Dividend / Share
Trailing annualized cash dividend
$0.00
Growth Streak
Consecutive years of dividend increases
0Y
3Y Div CAGR
—
5Y Div CAGR
—
Ex-Dividend Date
—
Payment Cadence
—
0 payments over the last 12 months
Buyback Engine
How much per-share support comes from repurchases
Repurchases (TTM)
Cash used for buybacks in the latest trailing period
$800M
Estimated Shares Retired
602.3K
Approx. Share Reduction
3.0%
Shares Outstanding
Current diluted share count from the screening snapshot
20M
At 3.0%/year, buybacks mechanically lift EPS even with flat earnings — each remaining share represents a slightly larger piece of the company.
FAQ
7 questionsMTD Investor Questions
Common questions answered from live analyst data and company financials.
01Is Mettler-Toledo International Inc. (MTD) stock a buy or sell in 2026?
Mettler-Toledo International Inc. (MTD) is rated Hold by Wall Street analysts as of 2026. Of 19 analysts covering the stock, 8 rate it Buy or Strong Buy, 11 rate it Hold, and 0 rate it Sell or Strong Sell. The consensus 12-month price target is $1491, implying +12.2% from the current price of $1328. The bear case scenario is $1010 and the bull case is $1887.
02What is the MTD stock price target for 2026?
The Wall Street consensus price target for MTD is $1491 based on 19 analyst estimates. The high-end target is $1600 (+20.5% from today), and the low-end target is $1445 (+8.8%). The base case model target is $1559.
03Is Mettler-Toledo International Inc. (MTD) stock overvalued in 2026?
MTD trades at 28.6x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals fairly valued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
04What are the main risks for Mettler-Toledo International Inc. (MTD) stock in 2026?
The primary risks for MTD in 2026 are: (1) Valuation & Market Volatility — MTD stock trades at a high price-to-earnings (P/E) multiple, which can lead to significant price fluctuations if the company misses earnings expectations. (2) Global Exposure & Economic Factors — Mettler-Toledo has considerable exposure to global R&D spending, particularly in China and Europe. (3) Insider Selling — Recent insider selling, including shares sold by the CFO, raises concerns about internal confidence in the company's future prospects. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
05What is Mettler-Toledo International Inc.'s revenue and earnings forecast?
Analyst consensus estimates MTD will report consensus revenue of $4.2B (+3.8% year-over-year) and EPS of $46.01 (+7.9% year-over-year) for the upcoming fiscal year. The following year, analysts project $4.3B in revenue.
06When does Mettler-Toledo International Inc. (MTD) report its next earnings?
Mettler-Toledo International Inc. is expected to report its next earnings on approximately 2026-05-07. Consensus expects EPS of $8.70 and revenue of $943M. Over recent quarters, MTD has beaten EPS estimates 92% of the time.
07How much free cash flow does Mettler-Toledo International Inc. generate?
Mettler-Toledo International Inc. (MTD) generated $849M in free cash flow over the trailing twelve months — a free cash flow margin of 21.1%. MTD returns capital to shareholders through and share repurchases ($800M TTM).